Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in LXEO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$269,768
-$97,731 QoQ
Shares Held
46,998
+27.0% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Derivatives in LXEO

reported options exposure · as of Mar 31, 2026
CallValue
$175,070
CallShares
30,500
PutValue
$57,400
PutShares
10,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. LXEO ranks #271 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LXEO

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $269,768 46,998
2026-03-31 $175,070 30,500
2026-03-31 $57,400 10,000
2025-12-31 $120,153 12,100
2025-12-31 $367,499 37,009
2025-12-31 $121,146 12,200
2025-09-30 $85,656 12,900
2025-09-30 $192,101 28,931
2025-06-30 $193,004 48,011
2025-03-31 $42,681 12,300
2025-03-31 $174,010 50,147
2024-12-31 $73,353 11,148
2024-03-31 $188,802 12,041